中文
We are committed to developing safe and
effective innovative drugs to combat the
serious threats posed by cancer and
autoimmune diseases
effective innovative drugs to combat the
serious threats posed by cancer and
autoimmune diseases
With well-established R&D and commercialization capabilities, InnoCare is dedicated to addressing
the huge unmet medical needs in the field of cancer and autoimmune diseases, by discovering and
developing first-in-class or best-in-class drugs globally.
the huge unmet medical needs in the field of cancer and autoimmune diseases, by discovering and
developing first-in-class or best-in-class drugs globally.
Dual A+H Listing and
Two Marketed Products
Two Marketed Products
Pipelines in
Clinical Stage
Clinical Stage
Clinical
Trials
Trials
R&D
Staff
Staff
Patents and Patent
Applications
Applications
Innovative Pipeline
Spotlight
InnoCare 2023 Results Snapshot
m
Revenue
b
Cash and Bank Balance
m
R&D Expenses
Jasmine Cui, Ph.D.
Co-founder, Chairwoman and CEO, InnoCare
“We are committed to developing high-quality innovative drugs and accelerating pipeline development for the benefit of patients worldwide!”
News
Subscription for Investor
To stay up-to-date with the latest information from InnoCare,
please subscribe to our investor newsletter
and select the categories to receive news and other information by email.
please subscribe to our investor newsletter
and select the categories to receive news and other information by email.
